Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis**Supported by a grant from Ortho-McNeil Pharmaceutical Corporation, Raritan, New Jersey.-Reference-Cited by-同舟云学术

Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis**Supported by a grant from Ortho-McNeil Pharmaceutical Corporation, Raritan, New Jersey.

Published:1996-06 Issue:6 Volume:65 Page:1100-1109
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Lobo Rogerio A.,Skinner Jonathan B.,Lippman Joel S.,Cirillo Sharlene J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference53 articles.

1. Metabolic aspects of oral contraceptives of relevance for cardiovascular diseases;Consensus Development Meeting;Am J Obstet Gynecol,1990

2. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases;Stampfer;N Engl J Med,1988

3. Coronary atherosclerosis and myocardial infarction in young women—role of oral contraceptives;Engel;Eur Heart J,1983

4. Cardiovascular death among women under 40 years of age using low-estrogen oral contraceptives and intrauterine devices in Finland from 1975–1984;Hirvonen;Am J Obstet Gynecol,1990

5. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study;Jacobs;Am J Epidemiol,1990

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review;Pharmaceuticals;2024-07-09

2. Sex differences in lipids: A life course approach;Atherosclerosis;2023-11

3. Control of side effects in strategy for increasing adherence to combined oral contraceptives. The role for a three-phase desogestrel-containing drug;Obstetrics, Gynecology and Reproduction;2022-06-27

4. Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review;Cureus;2022-05-17

5. Association of Hormonal Contraceptive Use With Adverse Health Outcomes;JAMA Network Open;2022-01-14